As of Apr 20
| +0.10 / +0.27%|
The 19 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 42.00, with a high estimate of 48.00 and a low estimate of 31.00. The median estimate represents a +14.66% increase from the last price of 36.63.
The current consensus among 23 polled investment analysts is to Hold stock in Pfizer Inc. This rating has held steady since April, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.